Scientific Review of Chlorozotocin (CZT)
Status: Listed in the Report on Carcinogens (RoC)
Primary Uses or Exposures: Chlorozotocin (CZT) is a cytostatic agent that is used in the investigational treatment of cancers of the stomach, large intestine, pancreas, and lung, melanoma, and multiple myeloma.
No Public Comments
- NTP Board of Scientific Counselors RoC Subcommittee Meeting (November 18–19, 1996)
Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, contact CDM (or use our contact form) and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.